Ecolab (ECL) call put ratio 2.5 calls to 1 put into quarter results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Ecolab Inc. (ECL) PT Raised to $292 at Citi
October 29, 2024 4:07 PM EDTCiti analyst Pat Cunningham raised the price target on Ecolab Inc. (NYSE: ECL) to $292.00 (from $290.00) while maintaining a Buy rating.
The analyst comments "Our three takeaways: 1) ECL noted its large clients have been receptive of the One Ecolab initiative. Mgmt remains... More
Morgan Stanley Reiterates Equalweight Rating on Ecolab Inc. (ECL)
October 29, 2024 10:10 AM EDTMorgan Stanley analyst Vincent Andrews reiterated an Equalweight rating and $240.00 price target on Ecolab Inc. (NYSE: ECL).
The analyst comments "We expect a mixed response to shares today. On one hand, the 3Q beat was modest and the low end of... More
Stifel Reiterates Buy Rating on Ecolab Inc. (ECL)
October 29, 2024 10:09 AM EDTStifel analyst Shlomo Rosenbaum reiterated a Buy rating and $283.00 price target on Ecolab Inc. (NYSE: ECL).
The analyst comments "While the revenue was a bit lower than expected (every unit but Pest had lower revenue than our estimate), the Adjusted EBIT and Adjusted EPS were better than... More

